Christopher Sullivan
Direttore Finanziario/CFO presso AVALO THERAPEUTICS, INC.
Patrimonio netto: 75 $ in data 30/04/2024
Posizioni attive di Christopher Sullivan
Società | Posizione | Inizio | Fine |
---|---|---|---|
AVALO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 14/02/2022 | - |
Comptroller/Controller/Auditor | 24/04/2020 | 14/02/2022 | |
Corporate Officer/Principal | 01/01/2018 | 24/02/2020 |
Storia della carriera di Christopher Sullivan
Precedenti posizioni note di Christopher Sullivan
Società | Posizione | Inizio | Fine |
---|---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2017 | 01/04/2018 |
OPGEN, INC. | Comptroller/Controller/Auditor | 01/11/2015 | 01/08/2017 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Formazione di Christopher Sullivan
University of Maryland | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Irlanda | 2 |
Posizioni
Comptroller/Controller/Auditor | 3 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
OPGEN, INC. | Commercial Services |
Aziende private | 2 |
---|---|
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Christopher Sullivan
- Esperienza